Tag: cancer
-
Liquid Biopsy for Solid Tumors Now Available
A test that inspects a patient’s blood sample for characteristic indicators of solid-tumor cancer, and can be part of a comprehensive precision analytics program, is now on the market.
-
Personalized Breast Cancer Trial Advances 7 Drugs
A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA.
-
A.I. to Identify Treatment Drivers for Colorectal Cancer
A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer.
-
Machine Learning Detects More Cancer Mutations
Medical researchers and data scientists developed a system for analyzing genomic data from cancer patients that accurately detects more cancer-causing mutations than other current techniques.
-
Genentech Gains Modular Engineered Antibodies in $5B Deal
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers.
-
A.I., Imaging Shown to Predict Immunotherapy Success
Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers.
-
M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency
M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency.
-
Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types.
-
Trial Testing Cancer Treatment Delivery Compound
A compound designed to help cancer therapies better penetrate and kill solid tumors is being tested in its first clinical trial among patients with pancreatic cancer.
-
Start-Up to Tackle Neurodegenerative Diseases, Raises $31 Million
A new company is forming to develop treatments that protect against destruction of brain cells in Alzheimer’s disease and comparable nerve damage from chemotherapy.